血小板第4因子
関連文献

“The control of angiogenesis and tumor invasion by platelet factor-4 and platelet factor-4-derived molecules”. Semin. Thromb. Hemost. 30 (1):  137–144. (2004). doi:10.1055/s-2004-822978. PMID 15034805.
“Roles of platelet factor 4 in hematopoiesis and angiogenesis”. Growth Factors 24 (4):  242–252. (2007). doi:10.1080/08977190600988225. PMID 17381065.
“Amino acid sequence of human platelet factor 4”. Proc. Natl. Acad. Sci. U.S.A. 74 (6):  2256–2258. (1977). doi:10.1073/pnas.74.6.2256. PMC 432148. PMID 267922. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC432148/.
Walz DA; Wu VY; de Lamo R et al. (1978). “Primary structure of human platelet factor 4”. Thromb. Res. 11 (6):  893–898. doi:10.1016/0049-3848(77)90117-7. PMID 601757.
“Antigenic and antiheparin properties of human platelet factor 4 (PF4)”. Blood 45 (4):  537–50. (1975). PMID 803847.
“Isolation, crystallization, and primary amino acid sequence of human platelet factor 4”. J. Biol. Chem. 252 (18):  6276–9. (1977). PMID 893407.
Maione TE; Gray GS; Petro J et al. (1990). “Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides”. Science 247 (4938):  77–79. doi:10.1126/science.1688470. PMID 1688470.
“Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura”. Br. J. Haematol. 74 (4):  395–401. (1990). doi:10.1111/j.1365-2141.1990.tb06325.x. PMID 2140694.
Poncz M; Surrey S; LaRocco P et al. (1987). “Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line”. Blood 69 (1):  219–23. PMID 3098319.
Griffin CA; Emanuel BS; LaRocco P et al. (1987). “Human platelet factor 4 gene is mapped to 4q12----q21”. Cytogenet. Cell Genet. 45 (2):  67–69. doi:10.1159/000132431. PMID 3622011.
Senior RM; Griffin GL; Huang JS et al. (1983). “Chemotactic activity of platelet alpha granule proteins for fibroblasts”. J. Cell Biol. 96 (2):  382–385. doi:10.1083/jcb.96.2.382. PMC 2112304. PMID 6187750. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2112304/.
“Complete covalent structure of human platelet factor 4”. Thromb. Haemost. 42 (5):  1652–60. (1980). PMID 6445090.
Deuel TF; Senior RM; Chang D et al. (1981). “Platelet factor 4 is chemotactic for neutrophils and monocytes”. Proc. Natl. Acad. Sci. U.S.A. 78 (7):  4584–4587. doi:10.1073/pnas.78.7.4584. PMC 319837. PMID 6945600. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC319837/.
“Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor”. Biochemistry 33 (46):  13918–13927. (1994). doi:10.1021/bi00250a047. PMID 7524669.
Mayo KH; Roongta V; Ilyina E et al. (1995). “NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: a symmetric tetramer”. Biochemistry 34 (36):  11399–11409. doi:10.1021/bi00036a012. PMID 7547867.
“Quarternary [sic] structure amplification of protein folding differences observed in 'native' platelet factor-4”. FEBS Lett. 357 (3):  301–304. (1995). doi:10.1016/0014-5793(94)01384-D. PMID 7835432.
Zhang X; Chen L; Bancroft DP et al. (1994). “Crystal structure of recombinant human platelet factor 4”. Biochemistry 33 (27):  8361–8366. doi:10.1021/bi00193a025. PMID 8031770.
Horne MK (1993). “The effect of secreted heparin-binding proteins on heparin binding to platelets”. Thromb. Res. 70 (1):  91–98. doi:10.1016/0049-3848(93)90226-E. PMID 8511754.
Kolset SO; Mann DM; Uhlin-Hansen L et al. (1996). “Serglycin-binding proteins in activated macrophages and platelets”. J. Leukoc. Biol. 59 (4):  545–54. doi:10.1002/jlb.59.4.545. PMID 8613703.